United States: CMS Proposes New Hardship Exemptions To Medicare eRx Penalties
Last Updated: July 31 2012
Article by Daniel F. Gottlieb

The Centers for Medicare and Medicaid Services has proposed two new significant hardship exemptions from the Medicare payment penalties under the Medicare Electronic Prescribing Incentive Program that would allow physicians who are not successful electronic prescribers under the program to avoid the penalties by adopting Certified Electronic Health Record (EHR) Technology and registering for the Medicare and Medicaid EHR Incentive Program and/or by achieving meaningful use under the EHR Incentive Program.

On July 6, 2012, the Centers for Medicare and Medicaid Services (CMS) proposed two additional "significant hardship" exemptions from the Medicare payment penalties for a physician or other eligible professional (EP) who fails to be a successful electronic prescriber under the Medicare Electronic Prescribing (eRx) Incentive Program.  The proposed exemptions, which were included as part of the calendar year (CY) 2013 Medicare Physician Fee Schedule (MPFS) proposed rule, address the challenge of meeting the overlapping eRx requirements of the eRx Incentive Program and the Medicare and Medicaid Electronic Health Record (EHR) Incentive Program, and recognize that there is little, if any, added benefit to the Medicare program when an EP meets both programs' eRx measures.

This On the Subject provides an overview of the eRx Incentive Program and discusses the two proposed additional hardship exemptions from the eRx penalties.

Overview of eRx Incentive Program

The Medicare Improvements for Patients and Providers Act of 2008 (MIPPA) established the five-year eRx Incentive Program beginning in 2009 to encourage electronic prescribing by paying incentive payments to EPs (or their group practices) who successfully e-prescribe for covered professional services furnished to Medicare beneficiaries (and reimbursed under the MPFS).  EPs are physicians and certain other professionals with prescribing authority for whom office visits, eye exams, psychotherapy or certain other services listed in the CMS eRx measure specifications represent at least 10 percent of their Medicare charges.

To be a successful electronic prescriber for 2012 and receive a 2012 eRx incentive payment, an EP must generate and transmit at least one electronic prescription during at least 25 unique office visits (or other services listed in the CMS eRx measure specifications) during 2012 and report those eRx events by using the eRx G-code, G8553, on the EP's Medicare Part B claims.  If an EP is a successful electronic prescriber in 2012 and 2013, the MPFS amount for covered professional services furnished by the EP during the year will be greater than the amount that would otherwise be payable by 1 percent for 2012 and 0.5 percent for 2013.

Beginning in 2012, MIPPA requires a penalty phase for EPs who are not successful electronic prescribers during 2012, 2013 and 2014.  If an EP is not a successful electronic prescriber for the applicable year, the MPFS amount for professional services furnished by such EP will be lowered by 1 percent for 2012, 1.5 percent for 2013 and 2 percent for 2014.

To avoid eRx penalties in CY 2013, an EP must report the eRx G-code for an electronic prescription (during a service listed in the eRx measure specification) at least 10 times for the January 1, 2012, through June 30, 2012, reporting period on the EP's Medicare Part B claims or qualify for one of the hardship exemptions.

Under the hardship exemptions, CMS may, on a case-by-case basis, exempt an EP from the requirement to be a successful electronic prescriber and from the eRx penalties, if CMS determines, subject to annual renewal, that meeting the requirement would result in a significant hardship for the EP.  In the CY 2012 MPFS final rule, CMS finalized the following four circumstances under which an EP or group practice may request consideration for a significant hardship exemption for the 2013 and 2014 eRx penalties:

  • The EP or group practice practices in a rural area with limited high-speed internet access.
  • The EP or group practice practices in an area with limited available pharmacies for electronic prescribing.
  • The EP or group practice is unable to electronically prescribe due to a local, state or federal law or regulation.
  • The EP or group practice generates fewer than 100 prescriptions during a six-month reporting period.

Proposed eRx Penalty Hardship Exemptions

The two proposed additional hardship exemptions to the eRx penalties for the 2013 and 2014 payment adjustments are discussed below.  CMS has specifically requested public comments on these two proposed exemption categories.  Comments are due by September 4, 2012.

EP Achieves Meaningful Use

Since an EP also must meet an e-prescribing measure to demonstrate meaningful use of Certified EHR Technology (as defined below) and receive EHR incentives payments under the EHR Incentive Program, CMS has proposed for the 2013 and 2014 eRx payment penalties, that an EP (or group practice) who demonstrates meaningful use during certain eRx payment penalty reporting periods would qualify for a significant hardship exemption.  Specifically, individual EPs (and EP members of a group practice) would need to achieve meaningful use for a continuous 90-day EHR reporting period (as defined for the EHR Incentive Program) that falls within the six-month reporting period (January 1 to June 30, 2012) for the 2013 eRx payment adjustment, or the 12- or six-month reporting periods (January 1 to December 31, 2012, or January 1 to June 30, 2013, respectively) for the 2014 eRx payment adjustment to be eligible to request a significant hardship exemption.  CMS also proposes that for purposes of the 2013 and 2014 eRx penalties the hardship exemption category would apply to individual EPs and group practices (that is, EP members of the group) that instead achieve meaningful use for an EHR reporting period that is the full CY 2012.

Certified EHR Technology is EHR technology that has been certified as meeting the U.S. Department of Health and Human Services Office of the National Coordinator of Health Information Technology's technological capability, functionality and security requirements for supporting the achievement of meaningful use under the EHR Incentive Program.  For more information on how EHR technology is certified, see McDermott's White Paper "Final Rule Establishes Permanent Certification Program for EHR Technology."

EP Demonstrates Intent to Participate in EHR Incentive Program

For the 2013 and 2014 eRx payment penalties, CMS has also proposed a significant hardship exemption category for EPs or group practices that have registered to participate in the EHR Incentive Program and adopted Certified EHR Technology prior to application of the respective payment penalties. CMS stated that this new hardship exemption is intended to reflect that adoption and implementation of Certified EHR Technology requires "installation, configuration, customization, training, workflow redesign and the establishment of connectivity with entities that facilitate electronic health information exchange (such as for electronic prescriptions)."

CMS stated that this proposal would be limited to EPs and group practices (1) that have not previously adopted Certified EHR Technology or received an incentive payment under the Medicare or Medicaid EHR Incentive Program, and (2) who attempt to participate in the Medicare and Medicaid EHR Incentive Program from January 2, 2012, through October 15, 2012, or the effective date of the final MPFS rule (which includes the six-month 2013 eRx penalty reporting period of January 1 to June 30, 2012) for the 2013 eRx penalties, or during the six-month eRx penalty reporting period for the 2014 eRx penalties (January 1 through June 30, 2013).

Proposed Deadlines and Procedures for Requesting Significant Hardship Exemptions

CMS proposes the following procedures and deadlines for requests for significant hardship exemptions from the 2013 and 2014 eRx penalties under the two proposed new exemption categories.

Process and Deadlines for 2013 eRx Penalties

CMS proposes that, in order to request a significant hardship under the two proposed significant hardship exemption categories for the 2013 eRx payment adjustment, CMS would analyze the information provided to it in the Registration and Attestation System under the EHR Incentive Program to determine whether the EP or group practice (that is, EP members of the group practice) has either (1) achieved meaningful use under the EHR Incentive Program during the applicable reporting periods discussed above, or (2) registered to participate in the EHR Incentive Program via the Registration and Attestation system for the EHR Incentive Program (accessible here) and adopted Certified EHR Technology, or both, if applicable.

EPs would be required to submit a significant hardship exemption request by October 15, 2012, or the effective date of the final rule for this provision, whichever is later, under both of the proposed exemptions.  For those EPs who request a significant hardship exemption based on achieving meaningful use under the EHR Incentive Program during the 12- or six-month reporting periods for the 2013 eRx penalties, CMS also proposes that the EP would be required to have attested to meaningful use under the EHR Incentive Program by October 15, 2012 (or if later, the effective date of the final rule), in order to qualify for a significant hardship exemption to the 2013 eRx penalties.  An EP requesting a significant hardship exemption for the 2013 eRx penalties under the second proposed significant hardship exemption category would be required to register for the EHR Incentive Program and adopt Certified EHR Technology by October 15, 2012 (or if later, the effective date of the final rule).

Process and Deadlines for 2014 eRx Penalties

CMS proposes to require 2014 eRx penalty exemption requests under the two proposed significant hardship exemption categories to be submitted via the communication support page (which is the method established for submitting the current significant hardship exemption categories) by June 30, 2013, which is also the submission deadline for the current exemption categories.  Under the first proposed new exemption category, an EP or group practice (that is, all EP members of the practice) that achieves meaningful use under the EHR Incentive Program during the six- or 12-month reporting periods for the 2014 eRx penalties would be required to attest by June 30, 2013. EPs requesting a significant hardship exemption for the 2014 eRx penalties under the second proposed significant hardship exemption category would also be required to register for the EHR Incentive Program and adopt Certified EHR Technology by June 30, 2013, in order to qualify for a significant hardship exemption.

The content of this article is intended to provide a general guide to the subject matter. Specialist advice should be sought about your specific circumstances.

To print this article, all you need is to be registered on Mondaq.com.

Click to Login as an existing user or Register so you can print this article.

More Popular Related Articles on Food, Drugs, Healthcare, Life Sciences from USA
By now you may have heard the news about a number of changes on the horizon for the Health Insurance Portability and Protection Act.
Whether you are an employer that provides health insurance for your employees, a business in the growing healthcare industry, a hospital, or other medical provider—or you provide services to any of those entities—you need to know about changes to the privacy and security rules under the Health Insurance Portability and Accountability Act of 1996 (HIPAA).
A summary of the most recent health care reform implementation updates.
In April 2013, the U.S. Department of Justice announced the settlement of five investigations with healthcare providers.
Understanding the complexities of the Health Insurance Portability and Accountability Act of 1996 (HIPAA) Privacy and Security Rules is often a challenge for health care providers and consumers.
Marilyn Tavenner received bipartisan support from members of the Senate Committee on Finance in her confirmation hearing to lead the Centers for Medicare and Medicaid Services (CMS) though a full Senate vote is being held up, the president released his FY 2014 budget proposal with health care reform and specified reimbursement reductions to providers and manufacturers totaling $400 billion over 10 years sprinkled throughout it, and Department of Health and Human Services (HHS) Secretary Sebelius
The Office of Inspector General for the Department of Health and Human Services has recently issued an updated Special Advisory Bulletin on the Effect of Exclusion from Participation in Federal Health Care Programs.
On Tuesday, the North Carolina legislature has enacted into law, pending the governor's signature, a prohibition on the use of most favored nations clauses in contracts between commercial health insurers and providers.
 
In association with
Tools
Print
Font Size:
Translation
Channels
Mondaq on Twitter
 
Register for Access and our Free Biweekly Alert
Email Address
Company Name
Password
Confirm Password
Mondaq Topics -- Select your Interests
Accounting and Audit
Anti-trust/Competition Law
Consumer Protection
Corporate/Commercial Law
Criminal Law
Employment and HR
Energy and Natural Resources
Environment
Family and Matrimonial
Finance and Banking
Food, Drugs, Healthcare, Life Sciences
Government, Public Sector
Immigration
Insolvency/Bankruptcy, Re-structuring
Insurance
Intellectual Property
International Law
Litigation, Mediation & Arbitration
Media, Telecoms, IT, Entertainment
Privacy
Real Estate and Construction
Strategy
Tax
Transport
Wealth Management
Regions
Africa
Asia
Asia Pacific
Australasia
Canada
Caribbean
Europe
European Union
Latin America
Middle East
U.K.
United States
Worldwide Updates

Terms & Conditions and Privacy Statement

Mondaq.com (the Website) is owned and managed by Mondaq Ltd and as a user you are granted a non-exclusive, revocable license to access the Website under its terms and conditions of use. Your use of the Website constitutes your agreement to the following terms and conditions of use. Mondaq Ltd may terminate your use of the Website if you are in breach of these terms and conditions or if Mondaq Ltd decides to terminate your license of use for whatever reason.

Use of www.mondaq.com

You may use the Website but are required to register as a user if you wish to read the full text of the content and articles available (the Content). You may not modify, publish, transmit, transfer or sell, reproduce, create derivative works from, distribute, perform, link, display, or in any way exploit any of the Content, in whole or in part, except as expressly permitted in these terms & conditions or with the prior written consent of Mondaq Ltd. You may not use electronic or other means to extract details or information about Mondaq.com’s content, users or contributors in order to offer them any services or products which compete directly or indirectly with Mondaq Ltd’s services and products.

Disclaimer

Mondaq Ltd and/or its respective suppliers make no representations about the suitability of the information contained in the documents and related graphics published on this server for any purpose. All such documents and related graphics are provided "as is" without warranty of any kind. Mondaq Ltd and/or its respective suppliers hereby disclaim all warranties and conditions with regard to this information, including all implied warranties and conditions of merchantability, fitness for a particular purpose, title and non-infringement. In no event shall Mondaq Ltd and/or its respective suppliers be liable for any special, indirect or consequential damages or any damages whatsoever resulting from loss of use, data or profits, whether in an action of contract, negligence or other tortious action, arising out of or in connection with the use or performance of information available from this server.

The documents and related graphics published on this server could include technical inaccuracies or typographical errors. Changes are periodically added to the information herein. Mondaq Ltd and/or its respective suppliers may make improvements and/or changes in the product(s) and/or the program(s) described herein at any time.

Registration

Mondaq Ltd requires you to register and provide information that personally identifies you, including what sort of information you are interested in, for three primary purposes:

  • To allow you to personalize the Mondaq websites you are visiting.
  • To enable features such as password reminder, newsletter alerts, email a colleague, and linking from Mondaq (and its affiliate sites) to your website.
  • To produce demographic feedback for our information providers who provide information free for your use.

Mondaq (and its affiliate sites) do not sell or provide your details to third parties other than information providers. The reason we provide our information providers with this information is so that they can measure the response their articles are receiving and provide you with information about their products and services.

If you do not want us to provide your name and email address you may opt out by clicking here .

If you do not wish to receive any future announcements of products and services offered by Mondaq by clicking here .

Information Collection and Use

We require site users to register with Mondaq (and its affiliate sites) to view the free information on the site. We also collect information from our users at several different points on the websites: this is so that we can customise the sites according to individual usage, provide 'session-aware' functionality, and ensure that content is acquired and developed appropriately. This gives us an overall picture of our user profiles, which in turn shows to our Editorial Contributors the type of person they are reaching by posting articles on Mondaq (and its affiliate sites) – meaning more free content for registered users.

We are only able to provide the material on the Mondaq (and its affiliate sites) site free to site visitors because we can pass on information about the pages that users are viewing and the personal information users provide to us (e.g. email addresses) to reputable contributing firms such as law firms who author those pages. We do not sell or rent information to anyone else other than the authors of those pages, who may change from time to time. Should you wish us not to disclose your details to any of these parties, please tick the box above or tick the box marked "Opt out of Registration Information Disclosure" on the Your Profile page. We and our author organisations may only contact you via email or other means if you allow us to do so. Users can opt out of contact when they register on the site, or send an email to unsubscribe@mondaq.com with “no disclosure” in the subject heading

Mondaq News Alerts

In order to receive Mondaq News Alerts, users have to complete a separate registration form. This is a personalised service where users choose regions and topics of interest and we send it only to those users who have requested it. Users can stop receiving these Alerts by going to the Mondaq News Alerts page and deselecting all interest areas. In the same way users can amend their personal preferences to add or remove subject areas.

Cookies

A cookie is a small text file written to a user’s hard drive that contains an identifying user number. The cookies do not contain any personal information about users. We use the cookie so users do not have to log in every time they use the service and the cookie will automatically expire if you do not visit the Mondaq website (or its affiliate sites) for 12 months. We also use the cookie to personalise a user's experience of the site (for example to show information specific to a user's region). As the Mondaq sites are fully personalised and cookies are essential to its core technology the site will function unpredictably with browsers that do not support cookies - or where cookies are disabled (in these circumstances we advise you to attempt to locate the information you require elsewhere on the web). However if you are concerned about the presence of a Mondaq cookie on your machine you can also choose to expire the cookie immediately (remove it) by selecting the 'Log Off' menu option as the last thing you do when you use the site.

Some of our business partners may use cookies on our site (for example, advertisers). However, we have no access to or control over these cookies and we are not aware of any at present that do so.

Log Files

We use IP addresses to analyse trends, administer the site, track movement, and gather broad demographic information for aggregate use. IP addresses are not linked to personally identifiable information.

Links

This web site contains links to other sites. Please be aware that Mondaq (or its affiliate sites) are not responsible for the privacy practices of such other sites. We encourage our users to be aware when they leave our site and to read the privacy statements of these third party sites. This privacy statement applies solely to information collected by this Web site.

Surveys & Contests

From time-to-time our site requests information from users via surveys or contests. Participation in these surveys or contests is completely voluntary and the user therefore has a choice whether or not to disclose any information requested. Information requested may include contact information (such as name and delivery address), and demographic information (such as postcode, age level). Contact information will be used to notify the winners and award prizes. Survey information will be used for purposes of monitoring or improving the functionality of the site.

Mail-A-Friend

If a user elects to use our referral service for informing a friend about our site, we ask them for the friend’s name and email address. Mondaq stores this information and may contact the friend to invite them to register with Mondaq, but they will not be contacted more than once. The friend may contact Mondaq to request the removal of this information from our database.

Security

This website takes every reasonable precaution to protect our users’ information. When users submit sensitive information via the website, your information is protected using firewalls and other security technology. If you have any questions about the security at our website, you can send an email to webmaster@mondaq.com.

Correcting/Updating Personal Information

If a user’s personally identifiable information changes (such as postcode), or if a user no longer desires our service, we will endeavour to provide a way to correct, update or remove that user’s personal data provided to us. This can usually be done at the “Your Profile” page or by sending an email to EditorialAdvisor@mondaq.com.

Notification of Changes

If we decide to change our Terms & Conditions or Privacy Policy, we will post those changes on our site so our users are always aware of what information we collect, how we use it, and under what circumstances, if any, we disclose it. If at any point we decide to use personally identifiable information in a manner different from that stated at the time it was collected, we will notify users by way of an email. Users will have a choice as to whether or not we use their information in this different manner. We will use information in accordance with the privacy policy under which the information was collected.

How to contact Mondaq

You can contact us with comments or queries at enquiries@mondaq.com.

If for some reason you believe Mondaq Ltd. has not adhered to these principles, please notify us by e-mail at problems@mondaq.com and we will use commercially reasonable efforts to determine and correct the problem promptly.